The SURMOUNT clinical trial program demonstrated average weight loss of 20.9% of body weight at the highest dose of tirzepatide over 72 weeks
Dull, uneven skin tone, patchy pigmentation, and that end-of-day dip in glow can feel never-ending, especially after sun or stress
Risk of Thyroid C-Cell Tumours: In studies with rodents, semaglutide caused thyroid C-cell tumours
The pricing structure remains flat across dose levelsyour dose may need to go up, but your price won'tensuring predictable, long-term affordability without surprise escalations
Protocol summary table Diet and lifestyle optimization for thyroid patients on tirzepatide Managing the dual demands of thyroid health and GLP-1 treatment requires thoughtful attention to nutrition, hydration, and daily habits